Table 1:

Projected estimates of new cases and age-standardized incidence rates for cancers in Canada in 2020, by sex

Type of cancer	No. of new cases			ASIR^*

	Total^†	Males	Females	In both sexes	Males	Females
All cancers^‡	225 800	115 800	110 000	519.4	557.8	491.2

Lung and bronchus	29 800	15 000	14 800	61.4	64.8	59.3

Breast	27 700	240	27 400	66.9	1.1	128.2

Colorectal	26 900	14 900	12 000	60.5	71.5	50.8

Prostate	23 300	23 300	NA	NA	116.7	NA

Bladder^§	12 200	9400	2800	25.0	42.0	10.7

Non-Hodgkin lymphoma	10 400	5800	4500	24.4	29.3	20.2

Thyroid	8600	2300	6400	22.5	11.7	33.1

Melanoma	8000	4400	3600	21.8	25.2	19.2

Kidney and renal pelvis	7500	4900	2600	17.3	23.6	11.5

Uterus (body, NOS)	7400	NA	7400	NA	NA	35.0

Leukemia	6900	4100	2800	16.5	21.1	12.6

Pancreas	6000	3100	2900	13.0	14.2	11.8

Oral	5400	3700	1650	12.8	18.5	7.5

Stomach	4200	2700	1450	9.4	13.1	6.1

Multiple myeloma	3400	2000	1450	7.8	9.7	6.1

Ovary	3100	NA	3100	NA	NA	14.2

Liver	3100	2300	810	6.8	10.6	3.3

Brain/CNS	3000	1700	1350	7.1	8.3	5.9

Esophagus	2400	1850	550	5.7	9.3	2.4

Cervix	1350	NA	1350	NA	NA	7.1

Testis	1150	1150	NA	NA	6.5	NA

Larynx	1150	980	180	2.3	4.1	0.7

Hodgkin lymphoma	1000	570	440	2.6	2.9	2.3

All other cancers	21 800	11 300	10 500	47.5	53.2	43.2

Note: ASIR = age-standardized incidence rate, CNS = central nervous system, NOS = not otherwise specified, NA = not applicable.
↵* Rates exclude those from Quebec.
↵† Column total may not sum to row totals owing to rounding.
↵‡ All cancers excludes nonmelanoma skin cancers (neoplasms, NOS; epithelial neoplasms, NOS; and basal and squamous).
↵§ Bladder cancer includes in situ carcinomas.